Quality of life and immune activation in patients with HIV-infection
- 31 August 2008
- journal article
- Published by Elsevier BV in Brain, Behavior, and Immunity
- Vol. 22 (6), 881-889
- https://doi.org/10.1016/j.bbi.2007.12.011
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- How Does Indoleamine 2,3-Dioxygenase Contribute to HIV-Mediated Immune DysregulationCurrent Drug Metabolism, 2007
- Acute psychotic symptoms in HIV-1 infected patients are associated with increased levels of kynurenic acid in cerebrospinal fluidBrain, Behavior, and Immunity, 2007
- Interferon-Induced Depression in Chronic Hepatitis C: A Review of Its Prevalence, Risk Factors, Biology, and Treatment ApproachesJournal of Clinical Gastroenterology, 2006
- Depression and HIV Infection: Impact on Immune Function and Disease ProgressionCNS Spectrums, 2003
- Kynurenic acid metabolism in the brain of HIV-1 infected patientsJournal of Neural Transmission, 2000
- Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurementsAIDS, 1998
- Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infectionImmunology Letters, 1991
- Implications of Interferon-Induced Tryptophan Catabolism in Cancer, Autoimmune Diseases and AidsAdvances in experimental medicine and biology, 1991
- Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1AIDS, 1989
- Psychiatric aspects of AIDSAmerican Journal of Psychiatry, 1987